DJIA 17,798.49 -14.90 -0.08%
NASDAQ 5,127.53 11.38 0.22%
S&P 500 2,090.11 1.24 0.06%
market minute promo

0.00 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CHTP 0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open 0.00
Previous Close 0.00
Daily Range 0.00 - 0.00
52-Week Range 0.00 - 0.00
Market Cap 0.0000
P/E Ratio 0.00
Dividend (Yield) 0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS -0.30




Drug Makers

Chelsea Therapeutics International Ltd. (CHTP) Description

A development stage pharmaceutical company that seeks to acquire and develop innovative products for the treatment of a variety of human diseases. Website:

News & Commentary Rss Feed

Here's What This $8 Billion Contrarian Has Been Buying

Does this 11.1% dividend yield interest you?

Lundbeck Delivers Some Data-Driven Upside

Chelsea Therapeutics Reports Clinical Trial Data on NORTHERA

Happy Birthday To Us! A Look Back At Market Musings

Chelsea Therapeutics Deal Terms: Be Careful

Chelsea Therapeutics - Going Private Transaction Provides Significant Upside

This Week in Biotech: Chelsea Therapeutics Finds a Buyer While Corcept Implodes

A small-cap buyout, the initiation of a nearly 4% dividend yield, strong late-stage psoriasis data for a big pharma duo, and a small-cap disaster "du jour" are this week's must-know stories in biotech.

JMP, Needham Doubtful Over Chelsea Therapeutics Receiving Additional Bids

Lundbeck Starting Slow, But Still Looking For The Big Finish

Stock Downgrades: Rocket Fuel Suffers Failure to Launch

Wall Street ratings agencies set the tone for today's stock market.

See More CHTP News...

CHTP's Top Competitors

CHTP 0.00 (0.00%)
Current stock: CHTP
AMGN $163.52 (-0.26%)
Current stock: AMGN
GILD $108.00 (0.20%)
Current stock: GILD
BIIB $293.21 (0.31%)
Current stock: BIIB